Release Date: 01/05/19 08:04 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 13.13MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%